"Identifying Red Flags For Off-Label Drug Use..."

Welcome to Connecting ALS. This week, we talk to Dr. Richard Bedlack, director of the Duke ALS Clinic and head of ALSUntangled, about a recent paper he co-authored laying out common red-flags patients need to know about when considering off-label treatments.

This week, Mike and Jeremy talk to Dr. Richard Bedlack, director of the Duke ALS Clinic and head of ALSUntangled, about a recent paper he co-authored laying out common red-flags patients need to know about when considering off-label treatments. Dr. Bedlack also weighs in on the ways technology adoption during the Covid-19 pandemic could change the future of medicine.

To learn more about the off-label red flags, go to https://www.als.org/stories-news/how-avoid-misleading-claims-about-label-prescription-drug-use

For a deeper dive on the red flags identified by ALSUntangled, check out https://www.tandfonline.com/doi/pdf/10.1080/21678421.2020.1765518?needAccess=true&

To revisit Dr. Bedlack’s earlier appearance on Connecting ALS click https://www.connectingals.org/episodes/alsuntangled-and-a-listening-tour

Learn more about the important work being done by ALSUntangled at http://www.alsuntangled.com/

Find a transcript of this episode soon on Tumblr.

This episode was produced by Garrett Tiedemann and is brought to you by The ALS Association’s national office and the Association’s Minnesota/North Dakota/South Dakota Chapter
Brought to you by The ALS Association. © 2020 The ALS Association